ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

The new international neuroblastoma response criteria

(2019) Katharine E. Orr et al.   PEDIATRIC RADIOLOGY

Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies

(2018) Helen Ma et al.   Current Hematologic Malignancy Reports

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

(2016) Manisha H. Shah et al.   INVESTIGATIONAL NEW DRUGS

Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors

(2016) Shingo Inaguma et al.   Oncotarget

Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program

(2013) Andrew C. Wood et al.   PEDIATRIC BLOOD & CANCER

The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

(2012) Naomi Pode-Shakked et al.   EMBO Molecular Medicine

Immunohistochemical Expression of Neural Cell Adhesion Molecule in Wilms Tumors, Nephrogenic Rests, and Fetal and Postnatal Renal Cortices

(2010) Payal Kapur et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Immunohistochemical Expression and Cluster Analysis of Mesenchymal and Neural Stem Cell–Associated Proteins in Pediatric Soft Tissue Sarcomas

(2010) Bekim Sadikovic et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma

(2009) Miikka Korja et al.   BMC CANCER

The Novel Chimeric Anti-NCAM (Neural Cell Adhesion Molecule) Antibody ch.MK1 Displays Antitumor Activity in SCID Mice but Does not Activate Complement-Dependent Cytolysis (CDC)

(2009) Martin Klehr et al.   JOURNAL OF IMMUNOTHERAPY

Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy

(2008) Kenji Ishitsuka et al.   BRITISH JOURNAL OF HAEMATOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status

(2008) Cynthia Winter et al.   PEDIATRIC BLOOD & CANCER

Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?

(2008) Robin Wachowiak et al.   PEDIATRIC SURGERY INTERNATIONAL